Patent · US Active

Assay and point of care device utilizing saliva for diagnosis and treatment of neurological conditions affecting brain health

US11717195B2 · kind B2 · utility

0Cited by
0References
2Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 6, 2017
Grant dateAug 8, 2023
Priority date
Expiry dateMay 19, 2041

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/60
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

The present invention relates to systems and methods for assessing brain health and detecting neurological conditions. The invention more particularly relates to systems and methods for diagnosing neurological conditions and analyzing rain health from analysis of a biological fluid sample, such as a saliva sample, that looks for and determines the significance of peripheral markers of blood-brain barrier disruption. The present invention further provides a diagnostic system and method with a higher negative predictive value of brain injury than currently known tests are able to provide, so as to reduce the need for computerized tomography or magnetic resonance imaging scans to affirmatively determine that brain or cerebrovascular injury has not occurred, and thus to improve suspected brain injury patient health care while reducing the expense of such care.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.